Lymphocyte Sub-populations and Auto Immune Diseases
NCT03901664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3500
Last updated 2019-04-03
Summary
To determine if artificial intelligence allow to detect lymphocyte subpopulations specific of diseases (such as primary Sjogren' syndrome and systemic lupus erythematosus) among patients with suspicion of autoimmune diseases.
Conditions
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-01
- Primary Completion
- 2018-04-01
- Completion
- 2018-04-01
Countries
- France
Study Locations
More Related Trials
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
IL-26 and Systemic Lupus Erythematosus
NCT01889641 ·Status: TERMINATED
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort
NCT02890134 ·Status: COMPLETED
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
NCT05479071 ·Status: UNKNOWN
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control
NCT02890147 ·Status: COMPLETED
-
Anti-nucleosome B Lymphocytes in Lupus
NCT01889654 ·Status: TERMINATED
-
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage
NCT04558814 ·Status: UNKNOWN ·Phase: NA
-
Systemic Lupus Erythematosus and Accelerated Aging
NCT05698173 ·Status: RECRUITING ·Phase: NA
-
Study of Leukocyte Populations in Patients With Chronic Inflammatory
NCT04749875 ·Status: NOT_YET_RECRUITING
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:
NCT02890121 ·Status: COMPLETED
-
Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE
NCT01702038 ·Status: WITHDRAWN ·Phase: PHASE2
-
Autoantibodies Prevalence During Checkpoint Inhibitor Treatment
NCT04220034 ·Status: COMPLETED
-
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus
NCT01196091 ·Status: COMPLETED ·Phase: PHASE3
-
A Model About the Response of Belimumab in SLE
NCT04893161 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
NCT07000916 ·Status: RECRUITING
-
Regulatory BCells in Systemic Lupus Erythematosus
NCT03178721 ·Status: UNKNOWN
-
Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry
NCT01729455 ·Status: COMPLETED
-
Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus
NCT07149402 ·Status: NOT_YET_RECRUITING
-
B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome
NCT04931160 ·Status: RECRUITING ·Phase: NA
-
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
NCT05843643 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)
NCT05394922 ·Status: RECRUITING
-
Anti-ficolin-2 Autoantibodies in Lupus Nephritis
NCT03063281 ·Status: COMPLETED
-
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
NCT05961267 ·Status: COMPLETED